234 related articles for article (PubMed ID: 32343673)
1. Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-
Fortner KA; Blanco LP; Buskiewicz I; Huang N; Gibson PC; Cook DL; Pedersen HL; Yuen PST; Murphy MP; Perl A; Kaplan MJ; Budd RC
Lupus Sci Med; 2020 Apr; 7(1):. PubMed ID: 32343673
[TBL] [Abstract][Full Text] [Related]
2. Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation.
Liao P; He Y; Yang F; Luo G; Zhuang J; Zhai Z; Zhuang L; Lin Z; Zheng J; Sun E
Arthritis Res Ther; 2018 Nov; 20(1):254. PubMed ID: 30419963
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.
Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ
Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.
Lood C; Blanco LP; Purmalek MM; Carmona-Rivera C; De Ravin SS; Smith CK; Malech HL; Ledbetter JA; Elkon KB; Kaplan MJ
Nat Med; 2016 Feb; 22(2):146-53. PubMed ID: 26779811
[TBL] [Abstract][Full Text] [Related]
5. Improved Mitochondrial Metabolism and Reduced Inflammation Following Attenuation of Murine Lupus With Coenzyme Q10 Analog Idebenone.
Blanco LP; Pedersen HL; Wang X; Lightfoot YL; Seto N; Carmona-Rivera C; Yu ZX; Hoffmann V; Yuen PST; Kaplan MJ
Arthritis Rheumatol; 2020 Mar; 72(3):454-464. PubMed ID: 31566908
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
Oaks Z; Winans T; Caza T; Fernandez D; Liu Y; Landas SK; Banki K; Perl A
Arthritis Rheumatol; 2016 Nov; 68(11):2728-2739. PubMed ID: 27332042
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum stress sensor IRE1α propels neutrophil hyperactivity in lupus.
Sule G; Abuaita BH; Steffes PA; Fernandes AT; Estes SK; Dobry C; Pandian D; Gudjonsson JE; Kahlenberg JM; O'Riordan MX; Knight JS
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561013
[TBL] [Abstract][Full Text] [Related]
9. Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2.
Yang B; Huang X; Xu S; Li L; Wu W; Dai Y; Ge MX; Yuan L; Cao W; Yang M; Wu Y; Deng D
Front Immunol; 2021; 12():756825. PubMed ID: 34721432
[TBL] [Abstract][Full Text] [Related]
10. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
[TBL] [Abstract][Full Text] [Related]
11. Altered Mitochondrial Homeostasis during Systemic Lupus Erythematosus Impairs Neutrophil Extracellular Trap Formation Rendering Neutrophils Ineffective at Combating
Monteith AJ; Miller JM; Williams JM; Voss K; Rathmell JC; Crofford LJ; Skaar EP
J Immunol; 2022 Jan; 208(2):454-463. PubMed ID: 34930781
[TBL] [Abstract][Full Text] [Related]
12. Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.
Fresneda Alarcon M; McLaren Z; Wright HL
Front Immunol; 2021; 12():649693. PubMed ID: 33746988
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus onset in lupus-prone B6.MRL/lpr mice Is influenced by weight gain and Is preceded by an increase in neutrophil oxidative burst activity.
Toller-Kawahisa JE; Canicoba NC; Venancio VP; Kawahisa R; Antunes LM; Cunha TM; Marzocchi-Machado CM
Free Radic Biol Med; 2015 Sep; 86():362-73. PubMed ID: 26117329
[TBL] [Abstract][Full Text] [Related]
14. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
Wirestam L; Arve S; Linge P; Bengtsson AA
Front Immunol; 2019; 10():2734. PubMed ID: 31824510
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.
Wiegman CH; Michaeloudes C; Haji G; Narang P; Clarke CJ; Russell KE; Bao W; Pavlidis S; Barnes PJ; Kanerva J; Bittner A; Rao N; Murphy MP; Kirkham PA; Chung KF; Adcock IM;
J Allergy Clin Immunol; 2015 Sep; 136(3):769-80. PubMed ID: 25828268
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps.
Watanabe H; Kubo M; Taniguchi A; Asano Y; Hiramatsu-Asano S; Ohashi K; Zeggar S; Katsuyama E; Katsuyama T; Sunahori-Watanabe K; Sada KE; Matsumoto Y; Yamamoto Y; Yamamoto H; Son M; Wada J
Clin Immunol; 2023 May; 250():109317. PubMed ID: 37015317
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus.
Buskiewicz IA; Montgomery T; Yasewicz EC; Huber SA; Murphy MP; Hartley RC; Kelly R; Crow MK; Perl A; Budd RC; Koenig A
Sci Signal; 2016 Nov; 9(456):ra115. PubMed ID: 27899525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
